BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:25 PM
 | 
Aug 20, 2007
 |  BC Extra  |  Company News

Solvay gets Creon approvable letter

Solvay (Euronext:SOLB) received an approvable letter from FDA for an NDA for Creon pancrelipase delayed-release capsules to treat pancreatic exocrine insufficiency, which is often associated with cystic fibrosis...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >